We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

On-Site DNA Analysis Could Soon Become Available

By HospiMedica International staff writers
Posted on 30 Dec 2008
A European Union- (EU)-funded project is in the process of developing a novel microsystem that could be used in a portable diagnostic device to analyze simultaneously and automatically various DNA samples with high precision.

The Smart-Biomems project (Rome, Italy) aims at developing a novel micro-total analysis system with fully integrated functionalities for diagnostic genotyping of point mutations and single nucleotide polymorphisms (SNPs). More...
The basis of the system relies on a MEMS (micro-electro mechanical system) platform. Since cancer is a particularly important potential field, the first prototype device is being developed for genotyping of clinically important mutations and common SNPs of the tumor protein 53 (TP53) gene, using tag-array minisequencing. Active flow control (AFC) components are specifically designed and integrated for appropriate control of heating and flow inside of a polymer-based microfluidic chip.

During testing, a liquidized DNA sample is inserted into the device, and a liquid plug fluid sample of a specific volume is then transferred into the microchip by a pressure control unit, which moves it through a network of micro-channels and chambers where the reactions take place. The entire process is automatic, eliminating the possibility of human error or contamination of the sample. The device is connected to a standard personal computer (PC) equipped with a camera capable of acquiring fluorescent images generated by the device. Proprietary software, specially developed by the EU project, analyzes the images and displays the test results on the computer monitor.

"We will use a known sample--where we know the mutations--and test the capability of the system to identify these mutations. We will then compare the results of our tests with results from a conventional testing procedure to check on the accuracy of the results and the time our microsystem takes to complete the analysis,” said project coordinator Mr. Gianluca Vezzani. "Should the prototype work, which we are sure it will do, we think it would take two to three years after the end of the project to see a commercial device, and these could be available by 2012. Right from the start, we have tried to design a cost-effective system.”

The TP53 protein acts as a tumor suppressor, regulating cell division. It is located in the cell nucleus, where it binds directly to DNA. When the DNA in a cell becomes damaged by agents such as toxic chemicals, radiation, or ultraviolet (UV) rays from sunlight, this protein plays a critical role in determining whether the DNA will be repaired or the damaged cell will undergo apoptosis. If the DNA can be repaired, tumor protein p53 activates other genes to fix the damage. If the DNA cannot be repaired, this protein prevents the cell from dividing and signals it to self-destruct. This process prevents cells with mutated or damaged DNA from dividing, which helps prevent the development of tumors.

Related Links:
Smart-Biomems Project


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.